Testimony Before the FDA’s Antimicrobial Drugs Advisory Committee Meeting about Sulopenem Etzadroxil/Probenecid for Uncomplicated Urinary Tract Infection September 9, 2024
Testimony Before the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee Regarding Donanemab for the Treatment of Alzheimer’s Disease June 10, 2024
Public Citizen’s Submission to the North Carolina State Health Plan on Achieving Sustainable Coverage of Weight-Loss Drugs June 4, 2024
Testimony Before the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee Regarding insulin icodec May 24, 2024
Report: Thirty-One Years of Pharmaceutical Industry Criminal and Civil Penalties: 1991-2021 May 21, 2024